Finance

Lists
28L:FRA
Peptonic Medical AB
€0.00020
0.00%
(0.00) 1D
Aug 12, 8:08:13 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 28L...
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.00
52-wk low
€0.00
No. of employees
2
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.00
52-wk low
€0.00
No. of employees
2
About Peptonic Medical AB
CEOErik Sundquist
Employees2
Founded2009
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.58M
3.54M
3.14M
2.87M
Cost of goods sold
1.44M
1.37M
1.02M
945.00K
Cost of revenue
1.44M
1.37M
1.02M
945.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.28M
10.07M
6.18M
4.12M
Operating expense
10.64M
1.17M
7.45M
5.63M
Total operating expenses
12.08M
2.54M
8.47M
6.58M
Operating income
-9.50M
998.00K
-5.33M
-3.71M
Other non operating income
-102.00K
1.00K
1.00K
68.00K
EBT including unusual items
-11.24M
-245.00K
-5.68M
-3.84M
EBT excluding unusual items
-11.24M
-245.00K
-5.68M
-3.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-90.00K
-10.33M
-166.00K
78.00K
Net income
-11.24M
-245.00K
-5.68M
-3.84M
Net profit margin
-435.50%
-6.92%
-181.13%
-133.88%
Earnings per share
-
-
-
-
Interest and investment income
-
16.00K
64.00K
-
Interest expense
-1.64M
-1.26M
-419.00K
-194.00K
Net interest expenses
-1.64M
-1.24M
-355.00K
-194.00K
Depreciation and amortization charges
1.44M
1.43M
1.44M
1.44M
EBITDA
-9.01M
1.48M
-4.85M
-3.23M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps